Got GLP-1s?
The Hidden Risks Behind the Weight Loss Craze
GLP-1 receptor agonists have quickly become some of the most talked-about drugs for weight loss and blood sugar control. Marketed as breakthrough solutions, they promise appetite suppression, improved glucose regulation, and significant weight reduction.
But beneath the surface, there are growing concerns—particularly when it comes to mental health, long-term safety, and how these drugs actually work in the body.
What Are GLP-1 Drugs?
GLP-1 stands for glucagon-like peptide-1, a hormone naturally produced in the gut. It helps regulate:
Blood sugar levels
Insulin secretion
Appetite and satiety
Drugs like semaglutide (found in Ozempic and Wegovy) are synthetic GLP-1 receptor agonists, meaning they are lab-created compounds designed to mimic this hormone.
Not “Lizard Saliva” — But Inspired by It
You may have heard people say these drugs come from “lizard venom” or “lizard saliva.” That’s not exactly accurate—but it’s not entirely baseless either.
The original discovery came from the Gila monster, a desert lizard whose venom contains a compound called exendin-4. This compound has a similar structure to human GLP-1 and can influence blood sugar regulation.
However, modern GLP-1 drugs are:
Fully synthesized in laboratories
Structurally modified for longer action in the body
Not directly harvested from lizards
So while they are inspired by a compound found in the Gila monster, what people are injecting today is a man-made pharmaceutical designed to mimic and amplify that biological effect.
The Mental Health Concerns
A growing body of research is raising serious red flags about the psychiatric effects of GLP-1 drugs.
A large study published in Nature, involving over 160,000 patients, found:
98% increased risk of psychiatric disorders
195% higher risk of major depression
106% increased risk of suicidal behavior
These are not small, dismissible side effects—they represent a significant shift in mental well-being for a large number of users.
Additional findings reported in the Journal of the American Medical Association showed:
Individuals taking semaglutide were 45% more likely to report suicidal thoughts compared to those on other medications.
European regulatory agencies have also been actively investigating reports of:
Suicidal ideation
Mood disturbances
Behavioral changes
The pattern is consistent and concerning.
How Do These Drugs Affect the Brain?
GLP-1 receptors are not just found in the gut—they are also present in the brain.
This means these drugs can influence:
Appetite centers
Reward pathways
Mood regulation systems
Blunting appetite may sound beneficial, but it often comes with broader neurological effects, including:
Reduced pleasure response
Emotional flattening
Changes in motivation
In some individuals, this can contribute to anxiety, depression, or more severe psychiatric outcomes.
Appetite Suppression at What Cost?
The mechanism behind these drugs is simple: make you eat less by altering internal signaling.
But this raises an important question:
Is long-term health really achieved by overriding the body’s natural hunger signals?
Or should we be addressing the root causes of:
Poor diet
Processed food consumption
Sedentary lifestyle
Metabolic dysfunction
Suppressing symptoms without correcting underlying behaviors can create a dangerous illusion of health.
A Word of Caution
The rapid rise in GLP-1 use has outpaced long-term safety data. Millions are now using these drugs—often for cosmetic weight loss rather than medical necessity.
At the same time, we are seeing:
Escalating reports of mental health issues
Ongoing regulatory investigations
Increasing dependency on pharmaceutical solutions
Choose Wisely
True health is not found in a syringe.
It is built through:
Intentional nutrition
Daily movement
Discipline and consistency
Addressing root causes—not masking symptoms
GLP-1 drugs may offer short-term results, but the potential cost—especially to mental health—deserves serious consideration.